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This work aims to contribute for the development of bioglass scaffolds to be used in bone tissue regeneration. Starting 
from the classic quaternarian composition of the bioglass 45s5 it was added potassium oxide and magnesium oxide in 
order to obtain the optimised system: SiO2-CaO-Na2O-MgO-K2O-P2O5, improving the mechanical resistance and the 
bioactivity behaviour. The mixture was reached by a fusion at 1500 ºC followed by thermal shock, the resulting bioglass 
was milled to get a particle size less than 40 µm and it was homogenised with a porogen agent (salt), resulting the 
pressed specimens at 100 MPa of 100, 60, 50, and 40 wt.% of bioglass. After sintering, bleaching and maturation, it was 
evaluated the mechanical behaviour, toxicity and bioactivity, proving the viability and potential of this simplified 
method of scaffold’s manufacture, also putting in evidence the advantages of the using salt as a porogen agent in the 
morphology and structure obtained. 
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1. INTRODUCTION 
Currently, the medicine in synergy with tissue 
engineering has been growing towards building porous 
scaffolds in order to repair or replace the bone tissue. In 
this study, we aim to construct a biomaterial reactive with 
high mechanical properties in order to be able to replace 
both the cortical and trabecular bone. 
The need of the bone tissue reconstruction promoted 
the progress of new biomaterials capable of replacing or 
optimizing traditional processes, designated as grafts. 
Synthetic biomaterials, such as calcium phosphates, 
present with controlled physico-chemical properties are 
considered a good alternative to grafts from other origins. 
These materials create a stable connexion with the neo-
formed bone. Examples of these are the hydroxyapatite 
(HA), calcium triphosphate and the bioglasses [1 – 3]. 
Ceramics like hydroxyapatite (HA- Ca10(PO4)(OH)4) 
and calcium phosphates were initially used in orthopedic 
field, namely biphasic calcium phosphate (BCP) and 
tricalcium phosphate (TCP), which stood out for the 
favourable properties: biocompatibility, due to the high 
chemical and structural similarities with the bone; bioinert; 
they create a porous structure, which facilitates cells 
infiltration and favors bone tissue growth [1, 4, 5]. 
However, these materials present several disadvantages 
that limit its use: brittleness, the difficulty to get a form to 
its implementation, the absence of structural holder 
brought about the fast reabsorption due to the 
macroporosity [6]. 
The bioactive glasses appeared in the 1960’s and are 
used in the orthopedic field, such as periodontal 
applications and maxillofacial and skull surgery, as it is the 
case of the quaternarian glass SiO2-CaO-Na2O-P2O5 
(Bioglass 45s5), which promote a chemical connection 
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through an apatitic bond with bone tissue and it presents 
excellent similarities with a trabecular bone [7]. In contact 
with body fluids, bioglasses enable HA deposition by 
stimulating a bonding function and ions controlled 
liberation, which promote cell proliferation with a 
consequent bone tissue formation. The high cells number 
of the trabecular bone and its high porosity (up to 80 %) 
are responsible for the high metabolic activity, promoting a 
fast modelling of the bone. However, several studies 
present limitations to the classical composition of bioglass 
45s5, but these can be improved by the addition of network 
modifiers oxides [8 – 10]. 
To mimic bone tissue is necessary to consider three 
key properties to reach values similar to bone, which are 
the bioactivity, mechanical properties and microstructure. 
Bioactivity of biomaterial is attributed to the formation of a 
HA polycrystalline layer on the bioglass surface in a 
physiological environment, which is influenced by the 
composition of the biomaterial. The constituent ions of 
bioglass 6P53-b are involved in bone metabolism, in 
mineralization process and in angiogenesis [11 – 13].  
On the other hand, the mechanical properties depend 
on the composition of the material microstructure and 
sintering process. The addition of magnesium oxide 
(MgO), justified as being one of the cortical bone 
constituent, allows an improvement in the cellular 
adhesion by promoting, during the thermal treatment, the 
strengthening of the layer. This is one advantage of the 
using a bioglass in the coating of metallic prosthesis, 
avoiding a too fast absorption of the bioglass, not allowing 
the substrate to touch the surrounding tissue and avoiding 
its possible displacement. The addition of sodium oxide 
(NaO) allows to increase chemical durability and 
potassium oxide (K2O) induces an increase in the 
devitrification of the network that favorable in bioactivity. 
In turn, the porogen agent allows to provide stability and 
maintain shape of the macropores to the densification 
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process occurs that during sintering which will lead to a 
strengthening of trabecular on synthesis process [14 – 16]. 
To obtain a macro porous microstructure it is crucial to 
use the porogen type since this provides the size and shape 
of porosity. One of the conventional methods used in 
creating porosity is the use of a porogen agent soluble 
during final processing (sintering or leaching), due to its 
low melting point or high solubility is removed providing 
the size and shape of macropores. Salt is a porogen agent 
very easy to remove and does not affect the conformation 
of the matrix, unlike most polymers due to their 
hydrophobicity are difficult to remove [17 – 21]. On the 
other hand, increasing the temperature for melting the 
polymer can modify the conformation of the matrix due to 
the crystallization effects. In addition, low chemical 
reactivity of the polymers due to its polarity, reduces the 
bioactivity of the biomaterial [18]. 
In this work the optimized composition of bioglass 
(6P53-b) is mixed with a porogen element (salt) resulting 
in a pore shape similar to the trabecular bone tissue, while 
promoting a resistant net during the sintering process and 
obtaining a more resistant structure especially after the 
maturation process. This bioglass material can be applied 
in the field of orthopedics such as: bone substitute; in 
surgery maxillofacial and periodontal; bone defects in that 
arise, due to trauma, bone loss, as well as on coating of 
prostheses in order to avoid contact between the substrate 
and the surrounding tissue which is the reason for the high 
number of infections and reducing the number of micro-
movements by fixing the prosthesis. 
2. MATERIALS AND METHODS 
Silicon dioxide (SiO2, Sigma-Aldrich, Spain), calcium 
oxide (CaO, Sigma-Aldrich, Spain), magnesium oxide 
(MgO, J. Vaz Pereira, Portugal), sodium oxide (Na2O, 
Sigma-Aldrich, Spain), phosphorus pentoxide (P2O5, 
Sigma-Aldrich, Spain) and potassium carbonate (K2CO3, 
Sigma-Aldrich, Spain) were used as ingredients of the 
bioglass “6P53-b”, in the proportions of 51, 19, 15, 9.8, 2.5 
and 1.8 wt.%, respectively. They were mixed 
(homogenized) and fused on a crucible at 1500 °C, during 
30 minutes, with a heating rate of 5 °C/minute, the mixture 
was then poured in water at room temperature to promote 
an abrupt cooling and avoid the crystallization, thus 
obtaining amorphous bioglass. 
The bioglass was ground on a ball mill to get particles 
of a size less then 40 µm (d 90 < 36.3 µm), obtained from 
size 325 mesh sieve (Restch, according to DIN-ISO 3310-
11) and controlled with a laser particle analyzer, Coulter 
LS200. The mixture, using a binder (acetone) with salt 
(porogen), at sizes between 212 and 425 µm (sieves of 70 
and 40 mesh), was performed at the ratio of 100, 60, 50 
and 40 wt.% and pressed (double effect) in a rigid matrix 
(316L stainless steel) at 100 MPa for 1 minute. 
The samples were dried at room temperature for 24 h 
and sintered at 725 °C for 3 hours, with heating rate of 
5 ºC/minute. The parameters of the cycle of sintering were 
determined after a DTA (differential thermal analysis) of 
the bioglass to guarantee amorphous specimens. The 
macroporosity obtained after bleaching the crystals of salt 
in thermostatic bath, Selecta Unitronic S320-100, with 
distilled water jet at 50 °C for 12 hours. Then the scaffold 
place submersed in distilled water for one week 
(maturation process). 
The porosity was analysed through porosimetry by 
intrusion of mercury (PIM), Autopore IV, model 9220 of 
Micrometrics Instrument. Also it was done 
interconnectivity tests to evaluate the existence of channels 
which interconnect the pores. The mechanical tests of 
compression were done with a universal Zwick‘s test 
machine, type 1435, with load cell up to 5 KN. Statistical 
analysis of the mechanical tests was obtained with a 
minimum of four independent and significant samples with 
dimensions of approximately 6 mm x 7 mm. 
The compounds values in the composition after the 
fusion and the thermal shock were confirmed through 
elementary analysis using SEM, Hitachi s-2700, with EDX 
module. An analysis of the homogeneity of the trabecular 
porous net of sample it was done through SEM images, by 
visualising the anchoring of the bioglass cells, the HA 
layer at the biomaterial surface (presence of HA by the 
variation of calcium and phosphorus ions). Using analysis 
of X-ray diffraction (XRD), Rigaku model DMAXIII/C, it 
proved that after sintering of the scaffolds of bioglass 
“6P53-b” it was amorphous [22]. 
Human osteoblastic cells were put into 23 cm3  
T-flasks with DMEM-F12 supplemented with heat 
inactivation and antibiotic/antimycotic solutions. When the 
cells reached confluence, they were subcultivated by 
incubation in Trypsin and EDTA for 3 – 5 minutes. Then 
the cells were centrifuged, resuspended in culture and put 
into a 75 cm3 T-flasks. Throughout this process, the cells 
were kept at 37 °C in a humidified atmosphere of 5 % of 
CO2 in an incubator [23, 24]. 
Human osteoblastic cells were cultivated in direct 
contact with small irregular pieces of bioglass in a 96-well 
plate, each formulation was added (n = 4), at a density of 
15 x 103 cells/well. After the incubation period (24, 48 and 
72 hours), cell viability was evaluated by reduction of 
MTS into a solution of formazan and water. The 
absorbance of the formazan was measured at 492 nm using 
a microplate reader (Sanofi, Pauster Diagnostics). The 
wells containing the cells in culture without bioglass 
samples were used as negative control (K-). The wells 
containing cells was added ethanol (96 %) corresponding 
to the positive control (K+). Cellular growth was monitored 
using an Olympus inverted light microscope, type CX41. 
These results presented are the mean ± standard deviation 
of at least five independent experiments. Statistical 
analysis was performed using one-way ANOVA with 
confidence of 95 %.  
The bioactivity of the bioglass samples was evaluated 
in vitro by observing the deposition of a layer of silica gel 
on the surface of each test piece to 100 %, 60 %, 50 % and 
40 % of bioglass after various immersion times in SBF. 
SBF was prepared in laboratory according to the protocol 
of Kokubo. Mineralization by the deposition tests were 
carried hydroxycarbonateapatite (HCA) leached by 
immersing samples in SBF to 1.7, 14, 21 and 28 days. To 
evaluate the deposition of HCA, samples were 
characterized after different periods of immersion by SEM 
and EDX to analyse quantitatively and morphologically 
HCA. 
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Fig. 1. Evolution of the specimens quality in function of the manufacture methodology optimization (homogenization, mould, acetone 
added): a – scaffold with cavities in the surface after the bleaching; b – differences in the homogeneity after sintering, 
delamination; c – scaffolds with an optimized mixture process 
 
During immersion, it is carried out systematically pH 
evaluation of each solution, so the pH variation promoted 
by the ion exchange between the SBF and bioglass was 
monitored. 
3. RESULTS AND DISCUSSION 
The synthesis of bioglass “6P53-b” yielded the raw 
material required for this work, without the need to 
purchase, and the proportions of ingredients was 
repeatedly confirmed by EDS. After thermal shock there 
has been no change in the properties of the bioglass as to 
its transparency and translucency. 
The sintering cycle was determined after DTA of the 
bioglass to guarantee amorphous specimens, T = 725 °C, 
since it allows complete densification of bioglass, avoid 
the crystallization phenomena that impair the bioactivity. 
Fig. 1 shows the evolution of the specimens during the 
optimization of the manufacture method. Fig. 1 a shows 
the scaffold with cavities in the surface after the bleaching; 
this is the result of a mixture with reduced homogeneity 
and excessive superficial agglomeration of salt. Fig. 1 b 
shows the differences in the homogeneity after sintering 
(delamination) caused by segregation as result of the 
excess of binder (acetone higher than 20 wt.%). Fig. 1 c 
shows the scaffolds with an optimized mixture process. 
The optimization of the manufacture method requires a 
homogenizing of the bioglass powders mixture, the 
quantity of added acetone, the compaction pressure in the 
molds and the sintering cycle without the crystallization of 
the bioglass samples. After obtaining the samples of 
bioglass it was proved by XRD its amorphous state. The 
Avrami crystallization kinetics for the bioglass samples is 
equal to 107.5 kJ/mol and the corresponding value of 
n = 1, which means that the crystallization tends to occur 
preferentially at the surface [25]. Fig.  2 shows, at low 
magnification, SEM morphology and macroporosity in the 
100 % bioglass samples, Fig. 2 a, and also in the samples 
with different relations of bioglass/salt of 60/40, Fig. 2 b, 
50/50, Fig. 2 c, and 40/60, Fig. 2 d. Fig. 2 a only shows the 
porosity coming from the particles packing of the 100 % 
bioglass and origin during the sintering cycle to obtain a 
non-crystalline sample. Fig. 2 b, c and d shows that the 
increase of salt addition leads to the formation of a porous 
network of a cubical shape structure with well defined 
boundaries.  
Fig. 3 shows, at high magnification, a detailed porous 
network shape, the thickness of its boundaries, the 
roughness and the sintering degree of the interconnecting 
bond. As expected, higher content of the porogen agent 
higher is the porosity of the sample. However, it is 
important to underline that the 100 % of bioglass samples 
show microporosity (~ 6.5 µm) explained by the imperfect 
packing of the particles distribution and by the sintering 
process to a value lower than the crystallization 
temperature. 
  
a b 
  
c d 
Fig. 2. SEM surfaces at low magnification (50x) for the samples: 
a – 100 % bioglass; b – 60 % bioglass; c – 50 % bioglass; 
d – 40 % bioglass 
Fig. 3 a shows a spherical interstice of the sample of 
the 100 % bioglass and Fig. 3 b shows a high similarity 
between the porous network, obtained through the action 
of the porogen agent and the network of the trabecular 
bone.  
Fig. 3. SEM surfaces at high magnification (1000x) for the 
samples with: a – 100 % bioglass; b – 60% bioglass 
A special emphasis goes to the result as being a porous 
network, which adds the interstitial porosity of 100 % 
bioglass with the porosity left by the salt during the 
sintering cycle and roughness, resulting in the presence of 
  
a b 
282 
 
well-defined trabecular and showing high densified and 
have high strength which will facilitate the cellular 
anchoring and the homogeneous distribution of the 
porosity with similar size and shape to the trabecular bone. 
The permeability of the sample bioglass, as well as the 
interconnectivity of the pores was examined visually by 
velocity of capillary adsorption of liquid dye (methylene 
blue), and quantified by the method of Archimedes, 
Table 1, where it occurs a gradual reduction of the bulk 
density (BD, g/cm3) and a growing water absorption  
(WA, %) of the samples with the increase of salt content. 
The porosity tests show that for the samples with 
higher bioglass tenor there is a bigger intrusion of mercury 
(more porous samples), because there is an expansion of 
the open pores area and an increase of the pore average 
diameter from 6.5 µm to 88 µm, correspond to the 
microporosity of the 100 % of bioglass samples and the 
macroporosity of the 40 % of bioglass samples, 
respectively. 
Table 1. Properties of the bioglass samples 
Bioglass, % 100 60 50 40 
BD, g/cm3 2.61 1.10 0.87 0.76 
WA, % 0.73 36.0 53.0 73.5 
Volume of intrusion, mL/g  0.059 0.397 0.770 0.996 
Area of porous, m2/g 0.001 0.030 0.055 0.065 
Average size of porous, μm  6.52 64.07 85.94 88.16 
Bone tissue does not have porosity with the same 
magnitude. There are a net of large pores and also very 
small cavities. In the samples produced a macro porosity 
with a distribution between 40 to 150 µm it is provide by 
the porogen agent (salt) while the micro porosity of 0.5 to 
10 µm is caused by the particle size distribution of bioglass 
raw materials and by the sintering conditions. The average 
pore size is close to the 90 µm. The dimension of the 
porous network is less than the desired, because during the 
sintering process and consequent densification of the 
bioglass structure it is observed a reduction of salt grains. 
This can be improved by the increase in the average size of 
the granulometric distribution of the porogen element 
(salt). 
A higher mechanical resistance is obtained in the 
samples with higher bioglass percentage, because they 
have a higher mechanical compression resistance due to 
trabecular of higher density. An efficient way to increase 
the compression mechanical resistance is to improve the 
quality of microstructure by increasing the density and 
decreasing the intergranular fissures (defects) through 
maturation methodology. Thus, maturation has promoted 
the structural development, coalescing reactions, 
dissolution and subsistence with the expulsion of the 
residual salt, improving the mechanical strength due to the 
minimization of the surface fissures and the foundation of 
crosslinks, observing a continued hardening of the bioglass 
matrix [26, 27]. 
The literature refer to compression mechanical 
resistance between 2 – 12 MPa for the trabecular bone 
[16, 24, 26, 28]. The results for the samples with 
maturation are within this interval, except for the 40 % 
bioglass, but when comparing the mechanical compression 
strength of this sample with higher porosity (around 90 %) 
with similar samples of the traditional bioglass 45s5, it was 
obtained a mechanical compression strength values about 
50 % higher [12, 14, 15]. 
The increase in mechanical strength is proportional to 
the increase of deformation, so observing a lower slope in 
the first part of the test (Young’s modulus lower) to first 
collapse of the trabecula, more fragile, of interconnecting 
between pores (point 1, Fig. 4). Follow a new gradual 
increase of the resistance supported by the trabecular 
network of the sample with greater rigidity (Young’s 
modulus higher) until the maximum strength and the 
following catastrophic rupture of the structure (point 2, 
Fig. 4). 
 
Fig. 4. Typical mechanical behaviour in compression of bioglass 
scaffolds 
The implementation of the maturation process after the 
samples sintering and its bleaching are factors“, which 
induce a higher mechanical strength (improvement of 
16 %); however, also it is important the bioglass 
composition and the cubic shape of the pore caused by the 
use of salt as porogen and principally the densification of 
the bioglass structure (trabecular network) during the 
sintering cycle [26, 29]. 
Through biological evaluation, by visualizing the 
adherence and cellular growth in all samples, it can be seen 
that all materials are biocompatible. The characterization 
of cytotoxic agents through MTS tests, Fig. 5, evidenced 
that the cells in contact with the bioglass samples had 
similar viability as the negative control one [23, 30]. 
 
Fig. 5. Cellular viability after 1, 2, 3, 4, 5, 6 and 7 days compared 
to the negative control (K-), positive control (K+) of the 
bioglass samples of 100 %, 60 %, 50 % and 40 % 
Furthermore, statistical analysis conducted for 7 day 
results show a statistically significant difference between 
the positive control of the cells exposed to bioglass and the 
negative control (with a statistically significancy adopted 
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for a p-value less than 0.001), proving that all samples are 
good candidates to biomedical applications. EDX analysis 
of the sample of 40 % bioglass, quantifies that the CA/P 
ratio is close to 1.3, corresponding to octacalcium 
phosphate (Ca8H2(PO4)6.5H2O). This metastable phase is a 
precursor of the HA phase (Ca/P = 1.67) [31, 32]. 
4. CONCLUSIONS 
A simplified method was used to obtain a raw material 
of bioglass composition, known in literature, with the 
designation of bioglass “6P53-b”. After mixed and 
homogenized with the porogen agent and the right amount 
of binder, it was obtained porous disks samples of bioglass 
by double effect pressure. Controlled sintering to obtain 
amorphous structures and bleaching process were 
appropriate to the achievement of high porosity network. 
The maturation process of the bioglass samples enabled a 
great improvement of the mechanical resistance and a 
microstructure with smaller number of defects and higher 
densification of the trabecular.  
The amount of 40 % of bioglass presents itself as a 
minimum limit due to the low mechanical resistance and 
the later absence of structural support. The compression 
resistance to the bioglass samples with maturation is inside 
of the values of the trabecular bone, except the 40 % 
bioglass sample, whose properties can be improved by 
adding reinforcement (fibers). Ever these samples (of 
higher porosity) have got a mechanical resistance 50 % 
higher than similar traditional bioglass (45s5). 
The cellular viability evidenced that the cells in 
contact with the bioglass samples had similar viability as 
the negative control, of all samples, inducing to cellular 
proliferation and superficial reactivity for the deposition of 
an HA intermediate, showing a good aptitude to a future in 
vitro analysis. 
This work contributed to the implementation of new 
synthesis techniques in order to obtain bioglass raw 
materials and added salt as porogen to promote macro 
porosity. The preliminary results show a path for further 
research focused on improve the chemical reactivity by 
optimizing the composition and improved of the 
mechanical properties of the scaffold to achieve the bone 
tissue values. 
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